| 【Company Research】I-Mab BioPharma (IMAB US) – Promising clinical results of lemzoparlimab in NHL |
| 【Company Research】Haidilao (6862 HK) – Awaiting positives to come after reforms |
| 【Company Research】Vanke - H (2202 HK) – Onewo’s spin-off a strong value boost for Vanke |
| 【Company Research】EVA Precision Industrial (838 HK) – Multiple growth drivers ahead |
| 【Sector Research】China Property Service Sector – NDRC to support Community VAS segment via tax and social insurance reduction |
| 【Sector Research】China Software & IT Services – China cloud outlook mixed |
| 【Company Research】WuXi Biologics (2269 HK) – Raised full-year guidance on strong business growth momentum |
| 【Sector Research】China Consumer Staples – Structural merits look prominent amid transitory headwind and any stagflation expectation |
| 【Company Research】Haier Smart Home (6690 HK) – Tough 4Q21E but guidance maintained |
| 【行业研究】开发商才是自己的救世主 |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
